Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1326 of 5804
-
Brain training shows promise for PTSD in veterans
Symptom relief Recruiting nowThe proposed study will test whether a working memory training (WMT) program improves fear extinction learning and its underlying neural circuitry in Veterans with posttraumatic stress disorder (PTSD). WMT is designed to improves the ability to maintain task-relevant information …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 26, 2026 14:25 UTC
-
Nigeria study: bundling health services boosts HPV shots for girls
Prevention CompletedThe goal of this clinical trial is to learn whether adding adolescent health services to routine government health programs can increase Human Papillomavirus (HPV) vaccination coverage among 9-year-old girls and improve use of other health services by adolescents in Nigeria. The …
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC
-
New PET scan agent could outshine MRI for prostate cancer detection
Diagnosis Completed68Ga-P16-093 is a novel radiotracer targeting PSMA. In this study, we investigated the diagnostic efficacy of 68Ga-P16-093 PET imaging (PET/CT or PET/MRI) in patients with newly diagnosed, treatment-naive prostate cancer, and performed a head-to-head comparison with multi-paramet…
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
Smart sensors could spot Parkinson's earlier and more accurately
Diagnosis Recruiting nowIn this project, ocular motor, pupil and gait data in people with Parkinson's disease (PD) will be collected in order to develop machine learning models for the diagnosis and monitoring of PD. With this, the investigators aim to advance the state of the art in PD diagnosis and mo…
Sponsor: machineMD AG • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
New drug cocktail aims to tame lupus kidney flares
Disease control Recruiting nowThis is a Phase IV, open-label, randomized trial to determine whether the combination of Belimumab (BEL) and Voclosporin (VCS), plus background therapy with Mycophenolate Mofetil (MMF), improves the proportion of patients with proliferative lupus nephritis achieving complete rena…
Phase: PHASE4 • Sponsor: NephroNet, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can common supplements prevent serious gut damage after poisoning?
Disease control OngoingThe goal of this clinical trial is to learn if N acetyl cysteine and vitaminD work to improve outcomes after corrosive ingestion in children. The main questions it aims to answer are: Does N acetyl cysteine and vitamin D decrease incidence of strictures after corrosive ingestio…
Phase: PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could raising blood pressure after clot removal improve stroke outcomes?
Disease control Recruiting nowThough intravenous thrombolysis has been shown to improve symptoms in acute ischemic stroke patients, the recanalization rate remains low (22.6%) and only around 30% of patients benefit from the treatment. Recently, endovascular thrombectomy using stent retrievers or catheters ha…
Phase: PHASE3 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for frail lung cancer patients: targeted drug repotrectinib under study
Disease control Recruiting nowROS1 rearrangements are rare, accounting for only 1-2% of NSCLC cases, but have been associated with response to ROS1 inhibitors, such as crizotinib and entrectinib. However, many patients develop resistance to the tyrosine-kinase inhibitors (TKIs), creating a need for new treatm…
Phase: PHASE2 • Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New hope for lung cancer patients when first targeted therapy stops working
Disease control Recruiting nowThis is a multicenter, open-label,randomised phase II study planned to include 60 subjects with EGFR-sensitive mutation advanced NSCLC after disease progression on first-line treatment with third-generation EGFR-TKI.Eligible patients will randomly be assigned in a 1:1:1 ratio to …
Phase: PHASE2 • Sponsor: Jialei Wang • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Pre-Surgery workouts may stop arm swelling in breast cancer patients
Prevention CompletedThis prospective prehabilitation study aims to evaluate the effects of an individualized exercise program initiated before breast cancer surgery and continued for 12 months postoperatively. The intervention focuses on incidence of breast cancer-related lymphedema, improving funct…
Phase: NA • Sponsor: University of Health Sciences Balikesir Hospital Eduation and Research • Aim: Prevention
Last updated Jun 27, 2026 08:06 UTC
-
Second radiation blast targets recurrent brain tumors
Disease control Recruiting nowBackground: Glioblastoma (GBM) is a cancer of the brain. Current survival rates for people with GBM are poor; survival ranges from 5.2 months to 39 months. Most tumors come back within months or years after treatment, and when they do, they are worse: Overall survival drops to l…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Vitamin c trial aims to boost quality of life in lung cancer patients
Symptom relief Recruiting nowThis is a two arm RCT evaluating the effect of intravenous vitamin C versus placebo in patients with incurable non-small cell lung cancer. Participants in both arms will be receiving platinum doublet chemotherapy with or without concurrent immunotherapy as standard care. We plan …
Phase: PHASE2 • Sponsor: The Canadian College of Naturopathic Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Could HIV drugs be the key to beating long COVID?
Symptom relief Recruiting nowThe trial will test if two repurposed HIV antivirals can reduce symptom burden in adult participants with Long Covid compared to placebo. Viral infection and viral reactivation have been documented in Long Covid. Participants will be randomly allocated to receive antivirals, Tru…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Custom 3D-Printed hip implants offer new hope for failed arthritis surgeries
Disease control Recruiting nowIn this prospective multicenter study, a population of adult individuals consecutively treated for revision hips, requiring a custom-made acetabular implant for non-oncological reasons, will be included. The custom-made implant is a personalized implant produced using additive ma…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Gamma globulin shows promise for critically ill children with inflammatory storms
Disease control Recruiting nowThe inflammatory storm in critically ill patients releases cytokines, causing systemic immune damage, which may be an important cause of multiple organ failure and even death. Inflammatory storms exacerbate the deterioration of the disease in those children. Gamma globulin may be…
Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New sleep drug shows promise for liver patients
Symptom relief CompletedSleep disturbance poses significant in patients with liver cirrhosis and is associated with impaired quality of life and worsening clinical status. Current pharmacological options remain limited and often have safety concerns due to altered hepatic metabolism. Lemborexant, a dual…
Phase: PHASE2 • Sponsor: Indonesia University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New clotting drug may cut bleeding risk in rare cancer surgery
Disease control Recruiting nowThis study is a phase 3, prospective, single center, randomized, open label, controlled, parallel arm, interventional study to investigate the efficacy and safety of CSL511, in participants undergoing cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIP…
Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a prostate cancer drug help fight kidney cancer?
Disease control Recruiting nowThis is a Phase I/II open-label, efficacy and safety study of bicalutamide in combination with sunitinib in patients with advanced renal cell carcinoma (RCC) who have been treated with a receptor tyrosine kinase inhibitor (RTKI) and experienced disease progression.
Phase: PHASE1, PHASE2 • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New study aims to help pregnant moms with HIV thrive
Disease control Recruiting nowThis study seeks to improve mental health, pregnancy, and HIV outcomes among pregnant and postpartum women living with HIV with common mental health disorders in Kenya. The investigators will tailor a collaborative care model for peripartum women with HIV experiencing mental heal…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Heart failure patients may skip hospital visits with digital home monitoring
Disease control Recruiting nowThis study aims to assess whether patients with acute heart failure (HF) can achieve the same level of HF-therapies by digital follow-up at home as compared to hospital visits according to the STRONG-HF strategy. Patients admitted to hospital with acute HF will be enrolled and ra…
Phase: NA • Sponsor: University Hospital, Akershus • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC